Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Transient Receptor Potential Cation Channel Subfamily V Member 1 market report explains the definition, types, applications, major countries, and major players of the Transient Receptor Potential Cation Channel Subfamily V Member 1 market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Amorepacific Corp

    • Flex Pharma Inc

    • DoNatur GmbH

    • Vitality Biopharma Inc

    • Pila Pharma AB

    • Toray Industries Inc

    • Kyowa Hakko Kirin Co Ltd

    • Grunenthal GmbH

    • Centrexion Therapeutics Corp

    • Medifron DBT Co Ltd

    • Amgen Inc

    • BCN Peptides SA

    • Daewoong Pharmaceutical Co Ltd

    • Sylentis SAU

    • Neurim Pharmaceuticals Ltd

    By Type:

    • CMX-020

    • CA-016

    • DD-04107

    • Others

    By End-User:

    • Ophthalmology

    • Immunology

    • Muscle Spasm

    • Pruritus

    • Abdominal Pain

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Transient Receptor Potential Cation Channel Subfamily V Member 1 Outlook to 2028- Original Forecasts

    • 2.2 Transient Receptor Potential Cation Channel Subfamily V Member 1 Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market- Recent Developments

    • 6.1 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market News and Developments

    • 6.2 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Deals Landscape

    7 Transient Receptor Potential Cation Channel Subfamily V Member 1 Raw Materials and Cost Structure Analysis

    • 7.1 Transient Receptor Potential Cation Channel Subfamily V Member 1 Key Raw Materials

    • 7.2 Transient Receptor Potential Cation Channel Subfamily V Member 1 Price Trend of Key Raw Materials

    • 7.3 Transient Receptor Potential Cation Channel Subfamily V Member 1 Key Suppliers of Raw Materials

    • 7.4 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Concentration Rate of Raw Materials

    • 7.5 Transient Receptor Potential Cation Channel Subfamily V Member 1 Cost Structure Analysis

      • 7.5.1 Transient Receptor Potential Cation Channel Subfamily V Member 1 Raw Materials Analysis

      • 7.5.2 Transient Receptor Potential Cation Channel Subfamily V Member 1 Labor Cost Analysis

      • 7.5.3 Transient Receptor Potential Cation Channel Subfamily V Member 1 Manufacturing Expenses Analysis

    8 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Export by Region (Top 10 Countries) (2017-2028)

    9 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Outlook by Types and Applications to 2022

    • 9.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global CMX-020 Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global CA-016 Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global DD-04107 Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Ophthalmology Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Immunology Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Muscle Spasm Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Pruritus Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Abdominal Pain Consumption and Growth Rate (2017-2022)

      • 9.2.6 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Analysis and Outlook till 2022

    • 10.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

      • 10.2.2 Canada Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

      • 10.2.3 Mexico Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

      • 10.3.2 UK Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

      • 10.3.3 Spain Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

      • 10.3.4 Belgium Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

      • 10.3.5 France Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

      • 10.3.6 Italy Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

      • 10.3.7 Denmark Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

      • 10.3.8 Finland Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

      • 10.3.9 Norway Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

      • 10.3.10 Sweden Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

      • 10.3.11 Poland Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

      • 10.3.12 Russia Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

      • 10.3.13 Turkey Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

      • 10.4.2 Japan Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

      • 10.4.3 India Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

      • 10.4.4 South Korea Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

      • 10.4.5 Pakistan Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

      • 10.4.6 Bangladesh Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

      • 10.4.7 Indonesia Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

      • 10.4.8 Thailand Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

      • 10.4.9 Singapore Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

      • 10.4.10 Malaysia Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

      • 10.4.11 Philippines Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

      • 10.4.12 Vietnam Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

      • 10.5.2 Colombia Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

      • 10.5.3 Chile Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

      • 10.5.4 Argentina Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

      • 10.5.5 Venezuela Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

      • 10.5.6 Peru Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

      • 10.5.7 Puerto Rico Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

      • 10.5.8 Ecuador Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

      • 10.6.2 Kuwait Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

      • 10.6.3 Oman Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

      • 10.6.4 Qatar Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

      • 10.7.2 South Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

      • 10.7.3 Egypt Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

      • 10.7.4 Algeria Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

      • 10.8.2 New Zealand Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption (2017-2022)

    11 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Competitive Analysis

    • 11.1 Amorepacific Corp

      • 11.1.1 Amorepacific Corp Company Details

      • 11.1.2 Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Main Business and Markets Served

      • 11.1.4 Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Flex Pharma Inc

      • 11.2.1 Flex Pharma Inc Company Details

      • 11.2.2 Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Main Business and Markets Served

      • 11.2.4 Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 DoNatur GmbH

      • 11.3.1 DoNatur GmbH Company Details

      • 11.3.2 DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Main Business and Markets Served

      • 11.3.4 DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Vitality Biopharma Inc

      • 11.4.1 Vitality Biopharma Inc Company Details

      • 11.4.2 Vitality Biopharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Vitality Biopharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Main Business and Markets Served

      • 11.4.4 Vitality Biopharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Pila Pharma AB

      • 11.5.1 Pila Pharma AB Company Details

      • 11.5.2 Pila Pharma AB Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Pila Pharma AB Transient Receptor Potential Cation Channel Subfamily V Member 1 Main Business and Markets Served

      • 11.5.4 Pila Pharma AB Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Toray Industries Inc

      • 11.6.1 Toray Industries Inc Company Details

      • 11.6.2 Toray Industries Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Toray Industries Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Main Business and Markets Served

      • 11.6.4 Toray Industries Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Kyowa Hakko Kirin Co Ltd

      • 11.7.1 Kyowa Hakko Kirin Co Ltd Company Details

      • 11.7.2 Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Main Business and Markets Served

      • 11.7.4 Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Grunenthal GmbH

      • 11.8.1 Grunenthal GmbH Company Details

      • 11.8.2 Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Main Business and Markets Served

      • 11.8.4 Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Centrexion Therapeutics Corp

      • 11.9.1 Centrexion Therapeutics Corp Company Details

      • 11.9.2 Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Main Business and Markets Served

      • 11.9.4 Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Medifron DBT Co Ltd

      • 11.10.1 Medifron DBT Co Ltd Company Details

      • 11.10.2 Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Main Business and Markets Served

      • 11.10.4 Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Amgen Inc

      • 11.11.1 Amgen Inc Company Details

      • 11.11.2 Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Main Business and Markets Served

      • 11.11.4 Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 BCN Peptides SA

      • 11.12.1 BCN Peptides SA Company Details

      • 11.12.2 BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Main Business and Markets Served

      • 11.12.4 BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 Daewoong Pharmaceutical Co Ltd

      • 11.13.1 Daewoong Pharmaceutical Co Ltd Company Details

      • 11.13.2 Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Main Business and Markets Served

      • 11.13.4 Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    • 11.14 Sylentis SAU

      • 11.14.1 Sylentis SAU Company Details

      • 11.14.2 Sylentis SAU Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 11.14.3 Sylentis SAU Transient Receptor Potential Cation Channel Subfamily V Member 1 Main Business and Markets Served

      • 11.14.4 Sylentis SAU Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio

      • 11.14.5 Recent Research and Development Strategies

    • 11.15 Neurim Pharmaceuticals Ltd

      • 11.15.1 Neurim Pharmaceuticals Ltd Company Details

      • 11.15.2 Neurim Pharmaceuticals Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 11.15.3 Neurim Pharmaceuticals Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Main Business and Markets Served

      • 11.15.4 Neurim Pharmaceuticals Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio

      • 11.15.5 Recent Research and Development Strategies

    12 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Outlook by Types and Applications to 2028

    • 12.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global CMX-020 Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global CA-016 Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global DD-04107 Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Ophthalmology Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Immunology Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Muscle Spasm Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Pruritus Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.5 Global Abdominal Pain Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.6 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Analysis and Outlook to 2028

    • 13.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

      • 13.2.2 Canada Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

      • 13.3.2 UK Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

      • 13.3.3 Spain Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

      • 13.3.5 France Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

      • 13.3.6 Italy Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

      • 13.3.8 Finland Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

      • 13.3.9 Norway Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

      • 13.3.11 Poland Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

      • 13.3.12 Russia Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

      • 13.4.2 Japan Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

      • 13.4.3 India Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

      • 13.5.3 Chile Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

      • 13.5.6 Peru Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

      • 13.6.3 Oman Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Transient Receptor Potential Cation Channel Subfamily V Member 1

    • Figure of Transient Receptor Potential Cation Channel Subfamily V Member 1 Picture

    • Table Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global CMX-020 Consumption and Growth Rate (2017-2022)

    • Figure Global CA-016 Consumption and Growth Rate (2017-2022)

    • Figure Global DD-04107 Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Ophthalmology Consumption and Growth Rate (2017-2022)

    • Figure Global Immunology Consumption and Growth Rate (2017-2022)

    • Figure Global Muscle Spasm Consumption and Growth Rate (2017-2022)

    • Figure Global Pruritus Consumption and Growth Rate (2017-2022)

    • Figure Global Abdominal Pain Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption by Country (2017-2022)

    • Table North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption by Country (2017-2022)

    • Figure United States Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Figure Canada Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Figure Mexico Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Table Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption by Country (2017-2022)

    • Figure Germany Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Figure UK Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Figure Spain Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Figure Belgium Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Figure France Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Figure Italy Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Figure Denmark Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Figure Finland Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Figure Norway Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Figure Sweden Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Figure Poland Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Figure Russia Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Figure Turkey Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Table APAC Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption by Country (2017-2022)

    • Figure China Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Figure Japan Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Figure India Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Figure South Korea Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Figure Thailand Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Figure Singapore Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Figure Philippines Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Table South America Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption by Country (2017-2022)

    • Figure Brazil Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Figure Colombia Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Figure Chile Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Figure Argentina Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Figure Peru Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Table GCC Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption by Country (2017-2022)

    • Figure Bahrain Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Figure Oman Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Figure Qatar Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Table Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption by Country (2017-2022)

    • Figure Nigeria Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Figure South Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Figure Egypt Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Figure Algeria Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Table Oceania Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption by Country (2017-2022)

    • Figure Australia Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption and Growth Rate (2017-2022)

    • Table Amorepacific Corp Company Details

    • Table Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Main Business and Markets Served

    • Table Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio

    • Table Flex Pharma Inc Company Details

    • Table Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Main Business and Markets Served

    • Table Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio

    • Table DoNatur GmbH Company Details

    • Table DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Main Business and Markets Served

    • Table DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio

    • Table Vitality Biopharma Inc Company Details

    • Table Vitality Biopharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Vitality Biopharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Main Business and Markets Served

    • Table Vitality Biopharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio

    • Table Pila Pharma AB Company Details

    • Table Pila Pharma AB Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pila Pharma AB Transient Receptor Potential Cation Channel Subfamily V Member 1 Main Business and Markets Served

    • Table Pila Pharma AB Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio

    • Table Toray Industries Inc Company Details

    • Table Toray Industries Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Toray Industries Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Main Business and Markets Served

    • Table Toray Industries Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio

    • Table Kyowa Hakko Kirin Co Ltd Company Details

    • Table Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Main Business and Markets Served

    • Table Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio

    • Table Grunenthal GmbH Company Details

    • Table Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Main Business and Markets Served

    • Table Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio

    • Table Centrexion Therapeutics Corp Company Details

    • Table Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Main Business and Markets Served

    • Table Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio

    • Table Medifron DBT Co Ltd Company Details

    • Table Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Main Business and Markets Served

    • Table Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio

    • Table Amgen Inc Company Details

    • Table Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Main Business and Markets Served

    • Table Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio

    • Table BCN Peptides SA Company Details

    • Table BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Main Business and Markets Served

    • Table BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio

    • Table Daewoong Pharmaceutical Co Ltd Company Details

    • Table Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Main Business and Markets Served

    • Table Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio

    • Table Sylentis SAU Company Details

    • Table Sylentis SAU Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sylentis SAU Transient Receptor Potential Cation Channel Subfamily V Member 1 Main Business and Markets Served

    • Table Sylentis SAU Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio

    • Table Neurim Pharmaceuticals Ltd Company Details

    • Table Neurim Pharmaceuticals Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Neurim Pharmaceuticals Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Main Business and Markets Served

    • Table Neurim Pharmaceuticals Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Portfolio

    • Figure Global CMX-020 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global CA-016 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global DD-04107 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ophthalmology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Immunology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Muscle Spasm Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pruritus Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Abdominal Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast by Country (2022-2028)

    • Table North America Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast by Country (2022-2028)

    • Figure United States Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast by Country (2022-2028)

    • Figure Germany Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast by Country (2022-2028)

    • Figure China Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast by Country (2022-2028)

    • Figure Brazil Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast by Country (2022-2028)

    • Figure Australia Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.